We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -2.35% | 20.75 | 20.50 | 21.00 | 21.25 | 20.75 | 21.25 | 233,974 | 12:42:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -2.49 | 54.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/10/2022 15:29 | 1.50 bid coming :-@ | amaretto1 | |
11/10/2022 15:23 | I must admit - it's hard to keep the faith when this is happening every day .. doesn't change a thing with AGL though .. funded and getting on with it | givmesunshine | |
11/10/2022 14:59 | It's funny how when the share price is down or weak ....The same characters appear ...And yes you guessed it ...Exactly the same rhetoric... nearly word for word ....Coincidence ? Or same shorting spread bet company...... they sold in to the ovarian news .. Suppressing the share price !!Come on Andrew LTS want some cheer | amaretto1 | |
11/10/2022 14:51 | Excellent points Fevertree - I concur. One hopes that AGL can secure one or more deals in the near term to give some support, but, AN needs to be in a different role and there certainly needs to be far greater accountability. Just look at the manner in which he arrogantly talks about only wanting certain types of shareholders, those in it for decades and with negligible regard for financial motive since he thinks his personal finances are secure - the chap needs to realise that investors are not in it to back his personal legacy or whatever he thinks is in it for him. | yasx | |
11/10/2022 14:18 | The rate this is dropping you won't be able to afford a Big Mac.LOLZ | 1liam | |
11/10/2022 14:07 | Only time I use a calculator is when I have to pay your mum. Her fees are getting lower and lower. Thats when shes not offering a 2 for 1 deal | zeus19 | |
11/10/2022 13:53 | Zeus19, There is something called a calculator on most devices these days. You should really utilise it.LOLZ | 1liam | |
11/10/2022 13:48 | There is something called a spell checker on most devices these days. You should really utilise it | zeus19 | |
11/10/2022 13:35 | No doubt you are vastly experienced & can tick the following boxes: corproate governace best practice; serving or former NED at listed company ; eexcutive managemetn exeprience in the sector and at a listed company......If so then you would not be blathering nonsense so |I'm guessing its no ticks in any of those boxes | fevertreeman | |
11/10/2022 13:30 | Before FDA my concerns were the same 1. Board composition 2. Commercial strategy Why would I be a long term investor here if I didnt believe we'd get FDA approval? I never thought it wouldnt get approved -my concerns have always been was AN et al capable of commercialising matters and getting on with the task of building the business. And that on the judgement of the market is where the jury is very much out I'm afraid. Newlands cannot continue to promise jam tomorrow : he's been in charge for long enough to know that he is not running a not for profit nor is he runnig a research institute. There seems no unrgency to bulk up the managemetn team and the only new arrival of any note left in pretty short order. The questions remain: "Is AN capable and willing to listen to advice?", "Is he being properly advised, and if so by whom?", "is he capable of working collaboratively given he has been one man band for so long" So far we havent had any encouragement that this is happening | fevertreeman | |
11/10/2022 12:45 | So you think corporate governance doesn’t matter? | henley2 | |
11/10/2022 12:45 | I meant Illumina taking them out ...Odviously not grail | amaretto1 | |
11/10/2022 12:44 | FTM. Before FDA you never claimed failings of AN or the board, you just kept harping on that Parsortix would never get FDA approval. Now that doesn't work anymore as an argument, you just keep deriding the board.You are so transparent as well as boring | asdb9 | |
11/10/2022 12:42 | This is a opportunity to add ... Not sell like bed wetters @ | amaretto1 | |
11/10/2022 12:41 | If i was Grail I'd take them out .. on a Strategic move ...To hedge the Illumina deal .... BG being one of there main shareholders to boot ..... U see over 30 percent is controllable..The rest high wealth individuals would take the low ball offer ...2.50 ..... AN would have no say !! | amaretto1 | |
11/10/2022 12:32 | The shorts have taken the shirt off your back again eh?You need to stop blaming the shorts for your decisions | truant2tb1 | |
11/10/2022 12:28 | Zzzzzzz come back when it's going up .... don't just appear on down days with your same old rhetoric !! | amaretto1 | |
11/10/2022 12:26 | I have been pointing out the dreadful corporate governance here ad nauseam. If Newlands wants to get proper credibility then the board needs a full refresh: 1. Best governance is not having a chairman since 2007 2. Best govcernance is proper alignment between NEDs and s/holders. There is very little skin in teh game from the NEDs.I think I'm right in saying one of them has no shares at all 3. Best governace is proper challenge to the executive - this is clearly not happening 4. Best governace is having the appropriate skill sets around the table to support the executive - the board is woefully underpowered given teh company's ambitions, and US orientation. The advisers really need to pull their fingers out and force change | fevertreeman | |
11/10/2022 12:03 | One issue which needs addressing is the lack of scrutiny of the the CEO’s performance by the Board of Directors. The Chairman has held his position since 2007. 9 years is the norm under corporate governance best practice rules. I just wonder how much independent scrutiny there is of AN’s performance? Didn’t stop him picking up a bonus last year of about 100% of base salary. I bet he gets a similar bonus this year for getting FDA approval and getting the capital raise away. Only good thing is that some of his LTIP awards are about to expire worthless, but I’m sure the remuneration committee will award him some more based on the achievements to date. Just don’t look at the share price! | henley2 | |
11/10/2022 11:59 | As for you ... FO | amaretto1 | |
11/10/2022 11:59 | Prove other wise !! | amaretto1 | |
11/10/2022 11:53 | sorry AMrto, thats rubbish. | hsdeo | |
11/10/2022 11:52 | amaretto1. Filtered | tday | |
11/10/2022 11:44 | Because I'm not supposed to know ..I've added today !! | amaretto1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions